Abstract
Objectives To analyse service use and variation for people with severe mental illness in the last year of life in Wales.
Methods This is an observational retrospective cohort study between 2018 – 2023 using anonymised linked routinely collected health datasets within a data dashboard.
Results We identified n=4722 (2.3%) deaths with ICD-10 codes for severe mental illness for the period 2018-2023. As a group people with severe mental illness die younger, are in receipt of specialist palliative care at lower rates, die more often in institutional settings rather than their own homes and comorbidity indicates more unscheduled care use in the last year of life.
Conclusions Unscheduled care use in the last year of life is associated with comorbidity indicating opportunities for upstream intervention to improve treatment, experience and quality of life for people with severe mental illness. Further investigation such as mixed methodological approaches to examine experiences of those with severe mental illness in the last year of life, and the human and systems factors influencing the nature and effectiveness of unscheduled delivery for this patient cohort alongside developments in data linkage that include general practice, social care, nursing and specialist palliative care inputs are needed.
What is already known on this topic There is little current data on people with severe mental illness in the last year of life, including service encounters such as unscheduled care. Routinely collected data for health service dashboards are a ready source that can provide new information on service use for this group.
What this study adds We now know how many people are dying in Wales with severe mental illness and their use of services in the last year of life. Comorbidity is associated with unscheduled service use and lower rates of specialist palliative care suggest a possible upstream intervention is possible.
How this study might affect research, practice or policy Detailed data linkage studies that make use of wider datasets including general practice, social care and nursing services are needed. Qualitative first-hand accounts from patients, their families and professionals could add new evidence. Specialist palliative care intervention earlier for patients with severe comorbidity may reduce use of unscheduled care.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interest VV is employed by the Digital Health and Care Wales. The Centre for Trials Research at Cardiff University receives infrastructure funding from Health & Care Research Wales. The authors declare no other competing interests.
Data availability statement The dashboard has been developed by Digital Health and Care Wales in collaboration with the Welsh Value in Health Centre and NHS Wales Palliative Care clinicians. Use of the data and access to the dashboard is available to all NHS Wales staff and a number of Welsh Government professionals. All queries and requests for further information can be directed to the Information Services team at dhcw.info{at}wales.nhs.uk.
Contributors All authors conceived and designed the study. VV prepared the dashboard data for analysis. MC performed the analysis for this paper. All authors contributed to the interpretation of the results. MC wrote the initial draft of the manuscript and all authors critically reviewed and approved the final version.
Competing Interest Statement
VV is employed by the Digital Health and Care Wales. The Centre for Trials Research at Cardiff University receives infrastructure funding from Health & Care Research Wales. The authors declare no other competing interests.
Funding Statement
The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Digital Health and Care Wales Innovation Board review classed this research as service evaluation and as such waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos